1. Home
  2. MBX vs MBUU Comparison

MBX vs MBUU Comparison

Compare MBX & MBUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBX
  • MBUU
  • Stock Information
  • Founded
  • MBX 36
  • MBUU 1982
  • Country
  • MBX United States
  • MBUU United States
  • Employees
  • MBX N/A
  • MBUU N/A
  • Industry
  • MBX
  • MBUU Marine Transportation
  • Sector
  • MBX
  • MBUU Industrials
  • Exchange
  • MBX NYSE
  • MBUU Nasdaq
  • Market Cap
  • MBX 762.6M
  • MBUU 812.7M
  • IPO Year
  • MBX 2024
  • MBUU 2014
  • Fundamental
  • Price
  • MBX $16.14
  • MBUU $41.54
  • Analyst Decision
  • MBX Strong Buy
  • MBUU Buy
  • Analyst Count
  • MBX 4
  • MBUU 7
  • Target Price
  • MBX $37.25
  • MBUU $44.33
  • AVG Volume (30 Days)
  • MBX 97.5K
  • MBUU 212.7K
  • Earning Date
  • MBX 11-07-2024
  • MBUU 10-31-2024
  • Dividend Yield
  • MBX N/A
  • MBUU N/A
  • EPS Growth
  • MBX N/A
  • MBUU N/A
  • EPS
  • MBX N/A
  • MBUU N/A
  • Revenue
  • MBX N/A
  • MBUU $744,785,000.00
  • Revenue This Year
  • MBX N/A
  • MBUU $4.07
  • Revenue Next Year
  • MBX N/A
  • MBUU $10.12
  • P/E Ratio
  • MBX N/A
  • MBUU N/A
  • Revenue Growth
  • MBX N/A
  • MBUU N/A
  • 52 Week Low
  • MBX $15.31
  • MBUU $30.20
  • 52 Week High
  • MBX $27.50
  • MBUU $56.03
  • Technical
  • Relative Strength Index (RSI)
  • MBX N/A
  • MBUU 48.38
  • Support Level
  • MBX N/A
  • MBUU $39.60
  • Resistance Level
  • MBX N/A
  • MBUU $41.81
  • Average True Range (ATR)
  • MBX 0.00
  • MBUU 1.45
  • MACD
  • MBX 0.00
  • MBUU -0.42
  • Stochastic Oscillator
  • MBX 0.00
  • MBUU 22.21

About MBX MBX BIOSCIENCES INC

MBX Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

About MBUU Malibu Boats Inc.

Malibu Boats is a leading designer and manufacturer of power boats in the United States. It is the market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a leading producer of sterndrive boats in the us in the 24- to 29-foot segment, in 2017 and Pursuit Boats, which makes high-end offshore and outboard motorboats, in 2018. In 2021, it purchased Maverick Boat Group, a leading seller of flat fishing boats, including bay, dual-console, and center-console boats. Malibu has also expanded into boat trailers and accessories and in 2020 began producing its own engines (Monsoon) for its performance sport boats and now for Cobalt. Malibu's target market includes a wide range of water enthusiasts who embrace the active outdoor lifestyle.

Share on Social Networks: